To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis

NCT01533844 · clinicaltrials.gov ↗
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated due to the fact that the required number of trial subjects was not met.

Conditions

Sponsor

Astellas Pharma Europe B.V.